Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^* BlueMountain Capital Management, LLC	2. Issuer Name and Ticker or Trading Symbol MedEquities Realty Trust, Inc. [ MRT ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __ X __ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below)
(Last) (First) (Middle) 280 PARK AVENUE, 12TH FLOOR	3. Date of Earliest Transaction (MM/DD/YYYY) 1/23/2019
(Street) NEW YORK, NY 10017 (City) (State) (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _ X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock ⁽¹⁾ ⁽²⁾ ⁽³⁾	1/23/2019		S		25000	D	$10.95	763988	I	Footnotes ⁽¹⁾ ⁽²⁾
Common Stock ⁽¹⁾ ⁽²⁾ ⁽³⁾	1/23/2019		S		25000	D	$10.92	738988	I	Footnotes ⁽¹⁾ ⁽²⁾
Common Stock ⁽¹⁾ ⁽²⁾ ⁽³⁾	1/23/2019		S		100000	D	$10.90	638988	I	Footnotes ⁽¹⁾ ⁽²⁾
Common Stock ⁽¹⁾ ⁽²⁾ ⁽³⁾	1/23/2019		S		25000	D	$10.85	613988	I	Footnotes ⁽¹⁾ ⁽²⁾
Common Stock ⁽¹⁾ ⁽²⁾ ⁽⁴⁾	1/24/2019		S		2699	D	$11.03	611289	I	Footnotes ⁽¹⁾ ⁽²⁾
Common Stock ⁽¹⁾ ⁽²⁾ ⁽⁴⁾	1/24/2019		S		100000	D	$11.00	511289	I	Footnotes ⁽¹⁾ ⁽²⁾
Common Stock ⁽¹⁾ ⁽²⁾ ⁽⁴⁾	1/24/2019		S		50000	D	$10.97	461289	I	Footnotes ⁽¹⁾ ⁽²⁾
Common Stock ⁽¹⁾ ⁽²⁾ ⁽⁴⁾	1/24/2019		S		25000	D	$10.95	436289	I	Footnotes ⁽¹⁾ ⁽²⁾
Common Stock ⁽¹⁾ ⁽²⁾ ⁽⁴⁾	1/24/2019		S		10000	D	$10.92	426289	I	Footnotes ⁽¹⁾ ⁽²⁾

*Table II - Derivative Securities Beneficially Owned ( e.g.* , puts, calls, warrants, options, convertible securities)**
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)			11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:
(1)	The filing of this Form 4 shall not be construed as an admission that BlueMountain Capital Management, LLC ("BMCM") is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any of the shares of Common Stock, par value $0.01 per share (the "Common Stock"), of MedEquities Realty Trust, Inc. (the "Issuer"). Pursuant to Rule 16a-1(a)(4) of the Exchange Act, BMCM disclaims such beneficial ownership, except to the extent of its pecuniary interest.
(2)	BMCM is the investment manager of Blue Mountain Credit Alternatives Master Fund L.P. ("BMCA"), BlueMountain Guadalupe Peak Fund L.P. ("BMGP"), BlueMountain Credit Opportunities Master Fund I L.P. ("BMCO"), BlueMountain Strategic Credit Master Fund L.P. ("BMSC") and BlueMountain Montenvers Master Fund SCA SICAV-SIF ("BMM" and, together with BMCA, BMGP, BMCO and BMSC, the "Funds"), which are the direct beneficial owners of 426,289 shares of Common Stock in the aggregate. BMCM, although it directs the voting and disposition of the Common Stock held by the Funds, only receives an asset-based fee relating to the Common Stock held by the Funds.
(3)	On January 23, 2019, BMCA, BMGP, BMCO, BMSC and BMM sold 6,949, 1,554, 6,949, 2,600 and 6,948 shares of Common Stock, respectively, for $10.95 per share, 6,949, 1,554, 6,949, 2,599 and 6,949 shares of Common Stock, respectively, for $10.92 per share, 27,794, 6,215, 27,795, 10,399 and 27,797 shares of Common Stock, respectively, for $10.90 per share and 6,949, 1,554, 6,948, 2,600 and 6,949 shares of Common Stock, respectively, for $10.85 per share.
(4)	On January 24, 2019, BMCA, BMGP, BMCO, BMSC and BMM sold 750, 168, 750, 281 and 750 shares of Common Stock, respectively, for $11.03 per share, 27,794, 6,215, 27,795, 10,399 and 27,797 shares of Common Stock, respectively, for $11.00 per share, 13,898, 3,107, 13,897, 5,199 and 13,899 shares of Common Stock, respectively, for $10.97 per share, 6,949, 1,554, 6,948, 2,600 and 6,949 shares of Common Stock, respectively, for $10.95 per share and 2,779, 621, 2,780, 1,040 and 2,780 shares of Common Stock, respectively, for $10.92 per share.

Remarks:
Elliot Mandelbaum, a former employee of BMCM, serves as a member of the board of directors of the Issuer as the representative of BMCM. In connection therewith, BMCM may be deemed to be a director by deputization of the Issuer solely for purposes of Section 16(a) of the Exchange Act. As a result, BMCM is listed a "Reporting Person" in Item 1 and the "Director" box is marked in Item 5 of this Form 4.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
BlueMountain Capital Management, LLC 280 PARK AVENUE, 12TH FLOOR NEW YORK, NY 10017	X

Signatures
BlueMountain Capital Management, LLC, By: /s/ Eric M. Albert, Chief Compliance Officer		1/25/2019
^** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.